Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an affinity
-
at the Harvard School of Dental Medicine invites individuals to apply for a postdoctoral fellow position investigating the cross-talk between cell signaling, metabolism, and immune regulation in stem cell biology
-
. Current approaches to vascularization include the co-culture of stem cells with endothelial cell lines. Furthermore, vascularization can be promoted by perfusing the cell culture with media and using
-
leukemia. MDS arise with the expansion of hematopoietic stem cells with genetic and/or cytogenetic alterations in the bone marrow. Proliferation of aberrant cell clones induces ineffective differentiation
-
computational biologists at the UCSF Parnassus campus. The Specialist will be a valued laboratory member, creating novel bioengineered stem cell platforms, assisting with grant preparation, and contributing
-
/10.26508/lsa.202201588 Pantier et al., Mol Cell (2021): https://doi.org/10.1016/j.molcel.2020.11.046 Candidate profile - Recently obtained PhD in genomics, molecular biology or other relevant discipline
-
modelling, stem cell biology (animal-/humanderived tissues), micro-physiological systems (MPS), organ-on-chip, zoonotic diseases, drug/vaccine testing and validation for zoonotic diseases, machine learning in
-
features. Using our recently developed chromosome engineering approach, we have created isogenic stem cell lines that allow us to precisely isolate the effects of the chromosomal abnormality from other
-
-activated cell sorting (FACS), and immunoprecipitation (IP). Maintains and differentiates human induced pluripotent stem cells (iPSCs) into specific cell lineages using established protocols and assist with
-
university hospitals in Western France) Follow-up of allogeneic stem cell transplant patients Thrombophilia testing (Factor V Leiden, Prothrombin G20210A mutation) In 2024, laboratory activity exceeded 9,000